Skip to main content
Top

Current Colorectal Cancer Reports

Issue 1/2017

Content (10 Articles)

Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Current Concepts on the Distal Margin of Resection of Rectal Cancer Tumors after Neoadjuvant Chemoradiation

Jonathan Imran, Jie J. Yao, Tarik Madni, Sergio Huerta

Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Current Status of the Watch-and-Wait Policy for Patients with Complete Clinical Response Following Neoadjuvant Chemoradiation in Rectal Cancer

Rob Glynne-Jones, Rob Hughes

Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Current Status of Laparoscopic Surgery in Colorectal Cancer

Marta Pascual, Marta Jiménez-Toscano, Miguel Pera

Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Robotic Surgery for Colon and Rectal Cancer: Current Status, Recent Advances, and Future Directions

Ajit Pai, George Melich, Slawomir J. Marecik, John J. Park, Leela M. Prasad

Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Lymphadenectomy in Colorectal Cancer: Therapeutic Role and How Many Nodes Are Needed for Appropriate Staging?

Jeonghee Han, Kyung Tae Noh, Byung Soh Min

Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Local Excision Versus Total Mesorectal Excision for Clinical Stage I (cT1–cT2) Rectal Cancer

Woramin Riansuwan, Varut Lohsiriwat

Radiation Therapy and Radiation Therapy Innovations in Colorectal Cancer (JY Wo, Section Editor)

The Impact of Novel Radiation Treatment Techniques on Toxicity and Clinical Outcomes in Rectal Cancer

Lara Hathout, Terence Williams, Salma K. Jabbour

Basic Science Foundations in Colorectal Cancer (J Roper, Section Editor)

Microsatellite Instability Pathway and EMAST in Colorectal Cancer

John M. Carethers

Personalized Medicine in Colorectal Cancer (D Cunningham and EC Smyth, Section Editors)

Molecular Stratification of Colorectal Cancer: Moving from the Laboratory to Clinical Practice

Michael Davidson, David Cunningham

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine